Pharmaceutical Johnson & Johnson on Thursday asked the Food and Drug Administration (FDA) to authorize the emergency use of its one-dose coronavirus vaccine,
after it announced that it is 72% effective.
Soon more information ...
Johnson & Johnson requests emergency authorization in the United States for its coronavirus vaccine
2021-02-04T23:31:11.532Z
It requires a single dose to immunize and is 72% effective, so it can be key to speeding up vaccination, which is now done only with Moderna and Pfizer drugs.